ArQule

1 stories about ArQule
default image

Pontifax Leads $9.5 Funding Round for Biopharmaceutical Company ArQule

19.11.17|CTech
Nasdaq-listed ArQule develops treatments for cancer and rare diseases
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1